James Thomson’s breakthrough in growing human embryonic stem cells in 1998 is worthy of the patents he received because no researchers had done what he did, the Wisconsin Alumni Research Foundation said Thursday, in response to the federal government’s preliminary rejection in March of three patents.
Office of Strategic Communication